Taking an idea sparked in a UB lab and bringing it to market to save lives and money
Orthopedic implant infections are caused by bacteria that attach and grow on the metal surface of the implant, forming a slime or “biofilm”. Many of the bacteria that cause infection are resistant to standard antibiotics, and the biofilm itself forms a barrier that protects even non-resistant the bacteria from antibiotic treatment and the immune system. If the biofilm is actually disrupted by antibiotics it tends to grow back, and “successful” antibiotic treatment can cause bacteria to detach from the joint area, enter the bloodstream, and infect the heart, causing severe complications.
The seed for the innovation was born in the laboratory of Mark Ehrensberger, associate professor in UB’s Department of Biomedical Engineering, a joint program of the School of Engineering and Applied Sciences and the Jacobs School of Medicine and Biomedical Sciences at UB. Ehrensberger developed the electrical-stimulation method that Garwood licensed from UB.
To bring the technology to market, Garwood partnered with the Buffalo Institute for Genomics and Data Analytics (BIG), which is part of Gov. Andrew M. Cuomo’s economic development efforts to further grow Buffalo Niagara as a hub for bioinformatics and life sciences.
Garwood also has been working with UB’s Center of Excellence in Materials Informatics, the UB Center for Advanced Technology in Big Data and Health Sciences, and the UB Center for Computational Research. Additionally, it recently was accepted into Empire State Development’s Technology Transfer Program.
Garwood’s goal is to eliminate the need for follow-up surgeries, wiping out infection-causing bacteria before it starts. Future applications for the technology could include prosthetics and dental implants.
With UB's incredible partnership, we will bring disruptive, life-saving products to the marketplace.
President & Chief Executive Officer
Garwood Medical Devices